'Glp 1' presentation slideshows

Newer Therapies For Diabetes

Newer Therapies For Diabetes. By Dr. Ganapathi. B Prof & head Dept. of Endocrinology St. johns Medical college, Bangalore. INTRODUCTION :. Discovery of insulin - Banting and Best in 1922 The last decade has witnessed an explosion in newer therapeutics. Inhaled/oral Insulin,

1.26k views • 102 slides

Weekly GLP1 Receptor Agonists

Weekly GLP1 Receptor Agonists. Major Metabolic Defects in Type 2 Diabetes. Physiopathology of diabetes includes multiple metabolic defects:1-4 Progressive ?-cell failure/decreased insulin secretion Insulin resistance ?- cell dysfunction ( hyperglucagonemia )

1.04k views • 92 slides

????????

????????. ??? 2009-04-24 (09:00-10:30) ??????? ????????? ????? (MD, PhD). MANAGEMENT OF TYPE 2 DIABETES. ORAL ANTIDIABETIC AGENTS (OAD) INSULIN. MANAGEMENT OF TYPE 2 DIABETES. ORAL ANTIDIABETIC AGENTS (OAD) INSULIN. ORAL ANTIDIABETIC AGENTS.

942 views • 67 slides

?????????? : ? ????? ??? ??????? DPP-4 ???? ????????? ??????? ????? 2

?????????? : ? ????? ??? ??????? DPP-4 ???? ????????? ??????? ????? 2. ?? ??????? ????????. ??????? ?????????? ???? ??? ???? ??????. ????????? ?????????? Sympathetic innervation (?-receptors) Parasympathetic (cholinergic) innervation. ??????? ( ?? ????? ?????? ). ?????????.

920 views • 55 slides

Marc Y Donath

600 views • 43 slides

Developments in the Treatment of T2DM

Developments in the Treatment of T2DM. Dr John Clark. 3 million. 2 million. Type 1. Type 2. 1 million. 0. 2013. 2000. 1995. Diabetes Prevalence. Audit of West Suffolk Hospital In-Patients. One day (23/9/12) 440 in-patients, in total, in WSH that day 75 known to have Diabetes

531 views • 42 slides

Attaining Glycemic Goals in Type 2 Diabetes: Diet & Exercise

Attaining Glycemic Goals in Type 2 Diabetes: Diet & Exercise. 6. 0. 5. 0. 4. 0. <7% (%). Proportion of Patients With. 3. 0. 1c. 2. 0. HbA. 1. 0. 0. 3. Y. e. a. r. s. 6. Y. e. a. r. s. 9. Y. e. a. r. s. Turner RC et al. JAMA. 1999;281:2005-2012.

521 views • 38 slides

Diabetes is emerging as the dominant healthcare epidemic

Diabetes is emerging as the dominant healthcare epidemic. Source: Diabetes Atlas 3rd Edition. www.eatlas.idf.org. Last accessed 25 January 2007. SA prevalence Diabetes = 5.5% Direct cause of death = 4.3% Contributory to 14% IHD, 12% hypertensive, 12% renal + 10% stroke deaths

474 views • 37 slides

Number and Percentage of U.S. Population with Diagnosed Diabetes, 1958-2008

457 views • 32 slides

Macrovascular

515 views • 31 slides

Antidiabetic medications and heart disease 26th April 2014, Kuwait

495 views • 31 slides

EXPLAINS

EXPLAINS. Hypoglycemia. EX PLAINS. Exogenous Insulin . Bolus Novolg Humolog Apidra Regular Exubera(inhaled Insulin ). Basal: Lantus Levemir NPH. ex p lains. Pituitary tumor (adrenal Insuficency, GH deficency ). exp l ains. Liver disease (Cirrhosis,Tumor)

460 views • 28 slides

Coventry Diabetes PLT Meeting

362 views • 26 slides

Overweight Children

Overweight Children. Ate fewer fruits and vegetables (2.9 vs. 3.3/day) Drank more sweetened beverages (1.3 vs. 1.1/day) Ate more high-fat snacks (64 vs. 56 %; p=0.054) Ate more fast food (1.4 vs. 1.1/week; p=0.051) Spent more screen time (101 vs. 81 minutes)

404 views • 26 slides

In the name of God

In the name of God. Gut Hormones in the control of appetite. Ali Haghzaheri. Introduction. Obesity is one of the greatest threats to the health it is essential to understand the physiology of appetite control

306 views • 20 slides

Madrid, 1 y 2 de marzo de 2013

Madrid, 1 y 2 de marzo de 2013. GLP-1 beyond the pancreas. GLP-1 and cardiovascular disease. GLP-1 and cardiovascular disease. GLP-1 and cardiovascular disease. CONCLUSIONES. CONCLUSIONES. CONCLUSIONES.

299 views • 18 slides

Heparin Sulfate in Normal Islets ( Alcina blue and Histochemistry staining)

Heparin Sulfate in Normal Islets ( Alcina blue and Histochemistry staining). Invading mononuclear cells of NOD mice express heparanase. NOD DM Prevention with inhibitor heparanase.

2.14k views • 14 slides

Small molecule-induced pancreatic exocrine transdifferentiation: Assay development

272 views • 14 slides

Table 2. Estimated Model Parameters

W-045. Fasting Glucose Model-Based Meta-Analysis: A Tool for Designing and Interpreting Early Diabetes Studies William S. Denney, Beesan Tan, and Gianluca Nucci Clinical Pharmacology, Pfizer PharmaTherapeutics R&D, Cambridge Laboratories, Pfizer Inc, Cambridge, MA 02139.

165 views • 1 slides

Two main categories of hormones influence food intake:

High-fat diet-induced obesity impairs the response to the satiety signal GLP-1 Diana L. Williams, Psychology Department & Program in Neuroscience. Introduction. HF-maintained rats gained significantly more weight than LF-maintained rats, as expected. HF. LF.

152 views • 1 slides